Digital blood test co Scopio Labs raises $50m
The company’s ultra-high quality and FDA-cleared imaging and AI analysis platforms enhance diagnostic capabilities and enable remote work.
Link to full article
In the media
Back to news lobby
April 14, 2026
Scopio Labs Secures EU IVDR Certification for the Industry-Only Full-Field Digital Bone Marrow Application
Latest Software Release Delivers DICOM Integration and Advanced Analysis Management to Meet Critical Market Requirements PARSIPPANY, N.J. – April 14, 2026 — Scopio Labs, the leader in Full-Field...
Read more
February 25, 2026
Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms
PARSIPPANY, N.J. — February 25, 2026 – Scopio Labs today announced it has achieved IVDR certification from BSI, a major regulatory milestone that clears the path for its AI-driven digital morphology...
Read more
July 31, 2025
First Of Its Kind AI-Powered Solution Fully Automates Blood Morphology
Scopio unveiled its groundbreaking Complete Blood Morphology (CBM) analyzer, bringing unprecedented scale, efficiency, and standardization to hematology.
Link to full article
